UNITED THERAPEUTICS CORP (UTHR) Stock Balance Sheet
NASDAQ:UTHR - US91307C1027 - Common Stock
403.8 USD
+14.46 (+3.71%)
403.8 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.59B | 1.70B | 1.21B | 961.20M | 894.80M | |||
| Marketable Securities | 1.46B | 1.57B | 1.79B | 1.88B | 1.04B | |||
| Receivables | 379.30M | 279.30M | 278.90M | 220.40M | 198.70M | |||
| Inventories | 169.20M | 157.90M | 111.80M | 102.00M | 93.80M | |||
| Other Current Assets | 229.70M | 169.70M | 166.20M | 219.20M | 100.40M | |||
| Total Current Assets | 3.83B | 3.87B | 3.55B | 3.38B | 2.32B | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.36B | 1.22B | 1.05B | 861.50M | 780.90M | |||
| Investments And Advances | 1.92B | 1.53B | 1.94B | 1.32B | 1.65B | |||
| Goodwill | N/A | 32.30M | 33.70M | 28.00M | 28.00M | |||
| Intangibles | 111.50M | 79.60M | 80.50M | 16.50M | 16.60M | |||
| Other Non-Current Assets | 689.50M | 621.50M | 518.10M | 442.00M | 370.10M | |||
| Total Non-Current Assets | 4.08B | 3.49B | 3.62B | 2.66B | 2.85B | |||
| TOTAL ASSETS | 7.91B | 7.36B | 7.17B | 6.04B | 5.17B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 300.00M | 400.00M | N/A | N/A | |||
| Accrued Expenses | N/A | 338.50M | 292.40M | 225.80M | 170.80M | |||
| Accounts Payable | 432.00M | 6.00M | 5.60M | 4.10M | 3.80M | |||
| Other Current Liabilities | 95.10M | 93.60M | 106.40M | 113.30M | 130.80M | |||
| Total Current Liabilities | 527.10M | 738.10M | 804.40M | 343.20M | 305.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 300.00M | 800.00M | 800.00M | |||
| Other Non-Current Liabilities | 207.30M | 181.90M | 77.80M | 104.60M | 104.80M | |||
| Total Non-Current Liabilities | 207.30M | 181.90M | 377.80M | 904.60M | 904.80M | |||
| TOTAL LIABILITIES | 734.40M | 920.00M | 1.18B | 1.25B | 1.21B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 7.85B | 7.22B | 6.03B | 5.04B | 4.32B | |||
| Additional Paid In Capital | 2.79B | 2.70B | 2.55B | 2.39B | 2.25B | |||
| Common Shares | 800.00K | 800.00K | 700.00K | 700.00K | 700.00K | |||
| Treasury Stock | -3.47B | -3.47B | -2.58B | -2.58B | -2.58B | |||
| Other Shareholders' Equity | 0.00 | -4.50M | -2.00M | 900.00K | -18.40M | |||
| Shares Outstanding | 45.22M | 44.83M | 47.04M | 46.00M | 45.10M | |||
| Tangible Book Value per Share | 156.19 | 141.24 | 124.80 | 103.31 | 86.79 | |||
| Total Shareholders' Equity | 7.17B | 6.44B | 5.98B | 4.80B | 3.96B | |||
| TOTAL LIABILITIES AND EQUITY | 7.91B | 7.36B | 7.17B | 6.04B | 5.17B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.05 | 0.17 | 0.20 | |||
| Current Ratio | 7.26 | 5.25 | 4.41 | 9.85 | 7.61 | |||
| Return On Assets (ROA) | 15.71% | 16.23% | 13.74% | 12.03% | 9.20% | |||
| Return On Equity (ROE) | 17.31% | 18.55% | 16.46% | 15.16% | 12.02% | |||
| Return On Invested Capital (ROIC) | 16.17% | 16.93% | 14.47% | 13.46% | 10.97% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 27.55% | 33.40% | 27.33% | 26.82% | 18.19% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 28.28% | 34.55% | 28.29% | 27.24% | 18.47% | |||
All data in USD , ROIC based on taxRate of 0.23